At Via Nova Therapeutics, our mission is to discover novel therapies for viral diseases, especially those arising from acute and subacute infections, and to efficiently bring these treatments to the clinic.
Via Nova is Latin for New Road.
The name reflects
(i) our plan to diverge from the established industry path, which is focused on chronic viral infections, and focus instead on acute and subacute infections; and
(ii) our belief that new, rapid at-home and point-of care diagnostics for these infections creates new opportunities to bring their treatments to the clinic.